Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
The New England Journal of Medicine|November 17, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 InfectionJordan J Feld, Ira M Jacobson, Christophe Hézode, et al.
Retrovirology|June 26, 2014
The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort studyStefania Bellino, Antonella Tripiciano, Orietta Picconi, et al.
The Journal of Infection|December 3, 2014
Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infectionCarmen Mirabelli, Matteo Surdo, Formijn Van Hemert, et al.
Plos One|November 19, 2010
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAARTBarbara Ensoli, Stefania Bellino, Antonella Tripiciano, et al.
The New England Journal of Medicine|November 18, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 InfectionGraham R Foster, Nezam Afdhal, Stuart K Roberts, et al.
Autoimmunity Reviews|February 10, 2011
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patientsMaurizio Pietrogrande, Salvatore De Vita, Anna Linda Zignego, et al.
The New Microbiologica|October 20, 2010
Performance of genotypic tropism testing in clinical practice using the enhanced sensitivity version of Trofile as reference assay: results from the OSCAR Study GroupValentina Svicher, Roberta D'Arrigo, Claudia Alteri, et al.
The New Microbiologica|March 2, 2012
Performance of genotypic tropism testing on proviral DNA in clinical practice: results from the DIVA study groupValentina Svicher, Claudia Alteri, Marco Montano, et al.
Pageof 7